In a new medical achievement, the Hamad Medical Corporation Heart Hospital in Qatar has begun using the latest advanced technology to treat atrial fibrillation, making it the first medical institution in the Middle East, and outside the United States and Europe, to use the advanced “FARAVIEW™” system.
Atrial fibrillation is one of the most common and dangerous heart rhythm disorders, which makes the heartbeat rapid and irregular, and may lead to serious complications such as strokes and heart failure.
The new Varavio system, developed by Boston International, specializes in treating atrial fibrillation. It allows doctors to have an unprecedented detailed view of the heart tissue, and to identify the areas responsible for the irregular heartbeat with extreme accuracy, which leads to enhancing the safety of the medical procedure and reducing its duration by directly targeting the abnormal tissue without affecting the healthy areas surrounding it, according to a statement issued by Hamad Medical Corporation on Wednesday, which reached Al Jazeera Health.
The introduction of this technology confirms the institution’s ongoing efforts to develop its therapeutic tools, and the readiness of its staff and infrastructure to absorb the latest medical innovations, ensuring patients have safer procedures, faster recovery, and better health outcomes in the long term.
This achievement represents a qualitative leap in the field of cardiac electrophysiology, and confirms Hamad Medical Corporation’s firm commitment to its strategy aimed at attracting the latest diagnostic and therapeutic technologies, and ensuring that all members of society in the State of Qatar have access to the highest levels of medical care available globally.